{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:20:36Z","timestamp":1793521236636,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["139748\/2024-5"],"award-info":[{"award-number":["139748\/2024-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301500\/2022-3"],"award-info":[{"award-number":["301500\/2022-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anti-PM\/Scl autoantibody has been associated with an overlap between polymyositis (PM) and systemic sclerosis (SSc). However, due to limited studies, the relevance of this autoantibody in patients with idiopathic inflammatory myopathies (IIMs) without SSc was analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This single-center retrospective cohort study was conducted between 2004 and 2024. A total of 93 adult patients with IIMs (66 with dermatomyositis and 27 with PM - EULAR\/ACR 2017) without SSc were included: 16 anti-PM\/Scl(+) and 77 anti-PM\/Scl(-). Patients with other types of IIMs, cancer-associated myositis, or overlap myositis, including SSc, as well as those with other myositis-specific and\/or myositis-associated autoantibodies were excluded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median age, sex distribution, and median follow-up duration were comparable between the anti-PM\/Scl(+) and anti-PM\/Scl(-) groups. There were no differences in clinical and laboratory characteristics, except for a higher frequency of lung involvement, joint involvement, \u201cmechanics\u2019 hand,\u201d \u201chiker\u2019s feet,\u201d and Raynaud\u2019s phenomenon, in contrast to a lower frequency of facial rash and \u201cV\u201d-neck sign in patients with anti-PM\/Scl(+) than in those with anti-PM\/Scl(-) (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Furthermore, patients with anti-PM\/Scl(+) exhibited a higher frequency of disease relapse (68.8% vs. 33.8%), disease activity (50.0% vs. 24.7%), and immunosuppressant use (methotrexate or azathioprine) at the last medical evaluation (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Severe infection and death rates were comparable between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Anti-PM\/Scl positivity was observed in 17.2% of the sample analyzed in the present study. Patients with this autoantibody present clinical manifestations resembling anti-synthetase syndrome, with increased disease relapse and activity rates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42358-025-00441-y","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:13:53Z","timestamp":1739556833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patients with anti-PM\/Scl-positive and idiopathic inflammatory myopathy resemble anti-synthetase syndrome"],"prefix":"10.1186","volume":"65","author":[{"given":"Rafaella do Amaral","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-4517","authenticated-orcid":false,"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"441_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primer. 2021;7:86.","journal-title":"Nat Rev Dis Primer"},{"key":"441_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/B978-0-323-98818-6.00023-6","volume":"195","author":"MC Dalakas","year":"2023","unstructured":"Dalakas MC. Autoimmune inflammatory myopathies. Handb Clin Neurol. 2023;195:425\u201360.","journal-title":"Handb Clin Neurol"},{"key":"441_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.46833\/reumatologiasp.2017.16.4.6-11","volume":"16","author":"SK Shinjo","year":"2017","unstructured":"Shinjo SK. Miopatias autoimunes sist\u00eamicas. Rev Paul Reumatol. 2017;16:6\u201311.","journal-title":"Rev Paul Reumatol"},{"key":"441_CR4","first-page":"129","volume":"24","author":"F Vandergheynst","year":"2006","unstructured":"Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, et al. Anti-PM\/Scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol. 2006;24:129\u201333.","journal-title":"Clin Exp Rheumatol"},{"key":"441_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/art.20056","volume":"50","author":"R Raijmakers","year":"2004","unstructured":"Raijmakers R, Renz M, Wiemann C, Egberts WV, Seelig HP, van Venrooij WJ, et al. PM-Scl-75 is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome. Arthritis Rheum. 2004;50:565\u20139.","journal-title":"Arthritis Rheum"},{"key":"441_CR6","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1093\/rheumatology\/keab433","volume":"60","author":"A Selva-O\u2019Callaghan","year":"2021","unstructured":"Selva-O\u2019Callaghan A, Simeon-Aznar CP. The scleromyositis phenotype. Lessons from a multicentre international cohort of anti-PM\/Scl-positive patients. Rheumatolology. 2021;60:4956\u20137.","journal-title":"Rheumatolology"},{"key":"441_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF00915286","volume":"4","author":"M Reichlin","year":"1984","unstructured":"Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, et al. Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol. 1984;4:40\u20134.","journal-title":"J Clin Immunol"},{"key":"441_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","volume":"6","author":"M Mahler","year":"2007","unstructured":"Mahler M, Raijmakers R. Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev. 2007;6:432\u20137.","journal-title":"Autoimmun Rev"},{"key":"441_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.1780351014","volume":"35","author":"CV Oddis","year":"1992","unstructured":"Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum. 1992;35:1211\u20137.","journal-title":"Arthritis Rheum"},{"key":"441_CR10","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s10067-022-06115-0","volume":"41","author":"JG J\u00fanior","year":"2022","unstructured":"J\u00fanior JG, Mugii N, Inaoka PT, Sampaio-Barros PD, Shinjo SK. Inflammatory myopathies overlapping with systemic sclerosis: a systematic review. Clin Rheumatol. 2022;41:1951\u201363.","journal-title":"Clin Rheumatol"},{"key":"441_CR11","first-page":"189","volume":"28","author":"E Wielosz","year":"2021","unstructured":"Wielosz E, Dryglewska M, Majdan M. The prevalence and significance of anti-PM\/Scl antibodies in systemic sclerosis. Ann Agric Environ Med AAEM. 2021;28:189\u201392.","journal-title":"Ann Agric Environ Med AAEM"},{"key":"441_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","volume":"77","author":"A V\u00e1ncsa","year":"2010","unstructured":"V\u00e1ncsa A, Gergely L, Ponyi A, Lakos G, N\u00e9meth J, Szodoray P, et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine. 2010;77:125\u201330.","journal-title":"Joint Bone Spine"},{"key":"441_CR13","first-page":"1","volume":"5","author":"SP Alves","year":"2018","unstructured":"Alves SP, Silva MG, Borges IBP, Shinjo SK. Patients with pure dermatomyositis\/polymyositis and anti-PM\/Scl autoantibody resembling anti-synthetase syndrome. MedicalExpress. 2018;5:1\u20137.","journal-title":"MedicalExpress"},{"key":"441_CR14","doi-asserted-by":"publisher","first-page":"102355","DOI":"10.1016\/j.autrev.2019.102355","volume":"18","author":"K Ussavarungsi","year":"2019","unstructured":"Ussavarungsi K, Nugent K, Gerke AK, Krasowski MD, Tuetken RS, Lenert PS. Interstitial lung disease associated with anti-PM-Scl antibody: a single center experience. Autoimmun Rev. 2019;18:102355.","journal-title":"Autoimmun Rev"},{"key":"441_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","volume":"162","author":"I Marie","year":"2010","unstructured":"Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, et al. Long-term outcome of patients with polymyositis\/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010;162:337\u201344.","journal-title":"Br J Dermatol"},{"key":"441_CR16","doi-asserted-by":"publisher","first-page":"778211","DOI":"10.3389\/fmed.2021.778211","volume":"8","author":"Y Ge","year":"2022","unstructured":"Ge Y, Shu XM, He L, Li C, Lu X, Wang G. Interstitial lung disease is a major characteristic of patients who test positive for anti-PM\/Scl antibody. Front Med. 2022;8:778211.","journal-title":"Front Med"},{"key":"441_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3899\/jrheum.090652","volume":"37","author":"JC Lega","year":"2010","unstructured":"Lega JC, Cottin V, Fabien N, Thivolet-B\u00e9jui F, Cordier JF. Interstitial lung disease associated with anti-PM\/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? J Rheumatol. 2010;37:1000\u20139.","journal-title":"J Rheumatol"},{"key":"441_CR18","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1212\/WNL.0000000000005638","volume":"90","author":"R De Lorenzo","year":"2018","unstructured":"De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C, et al. Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies. Neurology. 2018;90:2068\u201376.","journal-title":"Neurology"},{"key":"441_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jdcr.2023.08.016","volume":"41","author":"EH Kowalski","year":"2023","unstructured":"Kowalski EH, Kenney HM, Richardson CT. Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM\/Scl antibodies treated with intravenous immunoglobulin. JAAD Case Rep. 2023;41:26\u20139.","journal-title":"JAAD Case Rep"},{"key":"441_CR20","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1111\/1756-185X.13019","volume":"20","author":"A Kohara","year":"2017","unstructured":"Kohara A, Yanaba K, Muro Y, Ito H, Nakagawa H, Noda K, et al. Anti-PM\/Scl antibody-positive dermatomyositis in a Japanese patient: a case report and review of the literature. Int J Rheum Dis. 2017;20:2186\u20139.","journal-title":"Int J Rheum Dis"},{"key":"441_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"JC Lega","year":"2015","unstructured":"Lega JC, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V. Idiopathic inflammatory myopathies and the lung. Eur Respir Soc. 2015;24:216\u201338.","journal-title":"Eur Respir Soc"},{"key":"441_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13075-015-0573-x","volume":"17","author":"Y Muro","year":"2015","unstructured":"Muro Y, Hosono Y, Sugiura K, Ogawa Y, Mimori T, Akiyama M. Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma. Arthritis Res Ther. 2015;17:57.","journal-title":"Arthritis Res Ther"},{"key":"441_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.revmed.2010.04.004","volume":"31","author":"I Marie","year":"2010","unstructured":"Marie I, Lahaxe L, Tiev K, Duval-Modeste AB, Vittecoq O, Levesque H, et al. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review]. Rev Med Interne. 2010;31:540\u20134.","journal-title":"Rev Med Interne"},{"key":"441_CR24","first-page":"56531","volume":"16","author":"I Verma","year":"2024","unstructured":"Verma I, Dube AH, Kumbhalkar S, Nagpure K, Sawatkar G, Chuadhari SR, et al. A case of palmoplantar keratoderma in the constellation of connective tissue diseases. Cureus. 2024;16:56531.","journal-title":"Cureus"},{"key":"441_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ddg.15009","volume":"21","author":"J Sanz-Correa","year":"2023","unstructured":"Sanz-Correa J, Esteban-Vazquez A, Cobo-Ib\u00e1\u00f1ez T, Caelles IP, Sanz-Sanchez T, Cortes MDML, et al. Hiker\u2019s feet in a patient with anti-PM-Scl autoantibodies-associated idiopathic inflammatory myopathy. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2023;21:534\u20136.","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"441_CR26","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1111\/bjd.15371","volume":"176","author":"T Taki","year":"2017","unstructured":"Taki T, Muro Y, Ogawa Y, Akiyama M. Image Gallery: Palmoplantar hyperkeratosis in dermatomyositis with anti-PM\/Scl antibodies. Br J Dermatol. 2017;176:e94.","journal-title":"Br J Dermatol"},{"key":"441_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00296-021-05075-z","volume":"42","author":"D Srikantharajah","year":"2022","unstructured":"Srikantharajah D, Lloyd ME, Kiely PDW. Rituximab and intravenous immunoglobulin treatment in PM\/Scl antibody-associated disease: case-based review. Rheumatol Int. 2022;42:359\u201364.","journal-title":"Rheumatol Int"},{"key":"441_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","volume":"71","author":"C Marguerie","year":"1992","unstructured":"Marguerie C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, et al. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Med (Baltim). 1992;71:327\u201336.","journal-title":"Med (Baltim)"},{"key":"441_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","volume":"13","author":"JC Lega","year":"2014","unstructured":"Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev. 2014;13:883\u201391.","journal-title":"Autoimmun Rev"},{"key":"441_CR30","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955\u201364.","journal-title":"Ann Rheum Dis"},{"key":"441_CR31","doi-asserted-by":"crossref","unstructured":"Compston A. Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty\u2019s Stationery Office: 1942; p. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O\u2019Brien for the Guarantors of Brain. Saunders Elsevier: 2010; p. [8] 64 and 94 Figures. Brain. 2010;133:2838\u20132844.","DOI":"10.1093\/brain\/awq270"},{"key":"441_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MGP Cruellas","year":"2013","unstructured":"Cruellas MGP, Viana Vdos, ST, Levy-Neto M, de Souza FHC, Shinjo SK. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics. 2013;68:909\u201314.","journal-title":"Clinics"},{"issue":"2","key":"441_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.55563\/clinexprheumatol\/t7942l","volume":"40","author":"S Li","year":"2022","unstructured":"Li S, Gao S, Chen Q, et al. Clinical heterogeneities and prognoses of patients with myositis specific antibody negative dermatomyositis: a retrospective study in China. Clin Exp Rheumatol. 2022;40(2):284\u201391.","journal-title":"Clin Exp Rheumatol"},{"key":"441_CR34","doi-asserted-by":"publisher","first-page":"152529","DOI":"10.1016\/j.semarthrit.2024.152529","volume":"68","author":"F Espinosa-Ortega","year":"2024","unstructured":"Espinosa-Ortega F, Lodin K, Dastmalchi M, et al. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: a longitudinal multicenter study from the MYONET international network. Semin Arthritis Rheum. 2024;68:152529.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00441-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00441-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00441-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:13:57Z","timestamp":1739556837000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00441-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00441-y","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee (CAAE 34954620.5.0000.0068).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}